fanta.bio Sample: CNhs11716
20429 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1379 / 21491 (6.4%) | 454 / 214910 (0.2%) | −324.0 | −324.0 | 30.37 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1993 / 21491 (9.3%) | 822 / 214910 (0.4%) | −324.0 | −324.0 | 24.25 |
| HIF1A SRX11007095 | HK-2 Kidney | 2488 / 21491 (11.6%) | 1098 / 214910 (0.5%) | −324.0 | −324.0 | 22.66 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1951 / 21491 (9.1%) | 878 / 214910 (0.4%) | −324.0 | −324.0 | 22.22 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2774 / 21491 (12.9%) | 1323 / 214910 (0.6%) | −324.0 | −324.0 | 20.97 |
| FOXP1 SRX736067 | LNCAP Prostate | 2434 / 21491 (11.3%) | 1176 / 214910 (0.5%) | −324.0 | −324.0 | 20.70 |
| HIF1A SRX20663235 | HK-2 Kidney | 596 / 21491 (2.8%) | 294 / 214910 (0.1%) | −324.0 | −324.0 | 20.27 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2662 / 21491 (12.4%) | 1316 / 214910 (0.6%) | −324.0 | −324.0 | 20.23 |
| SCML2 SRX644728 | 293 Kidney | 1591 / 21491 (7.4%) | 855 / 214910 (0.4%) | −324.0 | −324.0 | 18.61 |
| MYH11 SRX265221 | ME-1 Blood | 1036 / 21491 (4.8%) | 681 / 214910 (0.3%) | −324.0 | −324.0 | 15.21 |
| MED1 SRX9419945 | BT-474 Breast | 4345 / 21491 (20.2%) | 3173 / 214910 (1.5%) | −324.0 | −324.0 | 13.69 |
| MED1 SRX9419944 | BT-474 Breast | 4232 / 21491 (19.7%) | 3174 / 214910 (1.5%) | −324.0 | −324.0 | 13.33 |
| BRD4 SRX9419935 | BT-474 Breast | 4275 / 21491 (19.9%) | 3210 / 214910 (1.5%) | −324.0 | −324.0 | 13.32 |
| MED1 SRX9419946 | BT-474 Breast | 4439 / 21491 (20.7%) | 3375 / 214910 (1.6%) | −324.0 | −324.0 | 13.15 |
| BRD4 SRX9419938 | BT-474 Breast | 4382 / 21491 (20.4%) | 3335 / 214910 (1.6%) | −324.0 | −324.0 | 13.14 |
| BRD4 SRX9419936 | BT-474 Breast | 4396 / 21491 (20.5%) | 3372 / 214910 (1.6%) | −324.0 | −324.0 | 13.04 |
| MED1 SRX9419947 | BT-474 Breast | 4290 / 21491 (20.0%) | 3317 / 214910 (1.5%) | −324.0 | −324.0 | 12.93 |
| BRD4 SRX9419937 | BT-474 Breast | 4223 / 21491 (19.7%) | 3305 / 214910 (1.5%) | −324.0 | −324.0 | 12.78 |
| EZH2 SRX2146136 | LNCAP Prostate | 10016 / 21491 (46.6%) | 9297 / 214910 (4.3%) | −324.0 | −324.0 | 10.77 |
| BRD4 SRX736201 | 90-8TL Neural | 7431 / 21491 (34.6%) | 7897 / 214910 (3.7%) | −324.0 | −324.0 | 9.41 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 856 / 21491 (4.0%) | 1155 / 214910 (0.5%) | −324.0 | −324.0 | 7.41 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2246 / 21491 (10.5%) | 3267 / 214910 (1.5%) | −324.0 | −324.0 | 6.87 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1699 / 21491 (7.9%) | 4580 / 214910 (2.1%) | −324.0 | −324.0 | 3.71 |
| KAT7 SRX101303 | RKO Digestive tract | 1930 / 21491 (9.0%) | 6252 / 214910 (2.9%) | −324.0 | −324.0 | 3.09 |
| AGO2 SRX4708039 | Hep G2 Liver | 2506 / 21491 (11.7%) | 9333 / 214910 (4.3%) | −324.0 | −324.0 | 2.69 |
| BRD1 SRX286203 | RKO Digestive tract | 1655 / 21491 (7.7%) | 5035 / 214910 (2.3%) | −321.0 | −317.9 | 3.29 |
| TP53 SRX19538279 | Osteoblasts Bone | 532 / 21491 (2.5%) | 338 / 214910 (0.2%) | −319.4 | −316.3 | 15.74 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 480 / 21491 (2.2%) | 238 / 214910 (0.1%) | −315.0 | −312.0 | 20.17 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1868 / 21491 (8.7%) | 6389 / 214910 (3.0%) | −308.8 | −305.7 | 2.92 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 788 / 21491 (3.7%) | 1138 / 214910 (0.5%) | −307.7 | −304.7 | 6.92 |
| Epitope tags SRX10549776 | K-562 Blood | 1877 / 21491 (8.7%) | 6472 / 214910 (3.0%) | −306.5 | −303.4 | 2.90 |
| PBX4 SRX2731658 | PC-3 Prostate | 1504 / 21491 (7.0%) | 33888 / 214910 (15.8%) | −305.7 | −302.7 | 0.44 |
| BRPF3 SRX796084 | RKO Digestive tract | 2034 / 21491 (9.5%) | 7576 / 214910 (3.5%) | −295.3 | −292.3 | 2.68 |
| TP53 SRX19538274 | U2OS Bone | 443 / 21491 (2.1%) | 215 / 214910 (0.1%) | −292.8 | −289.8 | 20.60 |
| BRPF3 SRX796085 | RKO Digestive tract | 1469 / 21491 (6.8%) | 4415 / 214910 (2.1%) | −288.4 | −285.4 | 3.33 |
| BRPF3 SRX796086 | RKO Digestive tract | 1953 / 21491 (9.1%) | 7192 / 214910 (3.3%) | −288.1 | −285.1 | 2.72 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 740 / 21491 (3.4%) | 1138 / 214910 (0.5%) | −276.2 | −273.2 | 6.50 |
| TP53 SRX19538268 | U2OS Bone | 429 / 21491 (2.0%) | 228 / 214910 (0.1%) | −275.0 | −272.0 | 18.82 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1395 / 21491 (6.5%) | 31023 / 214910 (14.4%) | −270.2 | −267.2 | 0.45 |
| AGO2 SRX6783957 | Hep G2 Liver | 1630 / 21491 (7.6%) | 5621 / 214910 (2.6%) | −264.7 | −261.7 | 2.90 |
| TP53 SRX19538276 | U2OS Bone | 418 / 21491 (1.9%) | 232 / 214910 (0.1%) | −263.9 | −260.9 | 18.02 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 623 / 21491 (2.9%) | 797 / 214910 (0.4%) | −263.3 | −260.4 | 7.82 |
| FOXA1 SRX176862 | MCF-7 Breast | 534 / 21491 (2.5%) | 17852 / 214910 (8.3%) | −262.4 | −259.6 | 0.30 |
| FOS SRX150477 | MCF 10A Breast | 1010 / 21491 (4.7%) | 25245 / 214910 (11.7%) | −262.3 | −259.4 | 0.40 |
| ING5 SRX286202 | RKO Digestive tract | 1752 / 21491 (8.2%) | 6390 / 214910 (3.0%) | −261.4 | −258.5 | 2.74 |
| TP53 SRX396254 | Fibroblasts Others | 1205 / 21491 (5.6%) | 3335 / 214910 (1.6%) | −260.9 | −258.1 | 3.61 |
| TP53 SRX19538267 | U2OS Bone | 390 / 21491 (1.8%) | 192 / 214910 (0.1%) | −256.5 | −253.7 | 20.31 |
| MEAF6 DRX234811 | 293 Kidney | 2206 / 21491 (10.3%) | 9340 / 214910 (4.3%) | −255.7 | −252.9 | 2.36 |
| FOS SRX150478 | MCF 10A Breast | 1067 / 21491 (5.0%) | 25823 / 214910 (12.0%) | −255.3 | −252.5 | 0.41 |
| Epitope tags DRX443510 | 293 Kidney | 1940 / 21491 (9.0%) | 7654 / 214910 (3.6%) | −254.5 | −251.7 | 2.53 |
| TP53 SRX19538280 | Osteoblasts Bone | 419 / 21491 (1.9%) | 262 / 214910 (0.1%) | −253.0 | −250.2 | 15.99 |
| FOXA1 SRX176863 | MCF-7 Breast | 504 / 21491 (2.3%) | 17037 / 214910 (7.9%) | −252.7 | −249.9 | 0.30 |
| AGO2 SRX6783958 | Hep G2 Liver | 1579 / 21491 (7.3%) | 5495 / 214910 (2.6%) | −252.6 | −249.8 | 2.87 |
| FOXA1 SRX4815197 | MCF-7 Breast | 1051 / 21491 (4.9%) | 25455 / 214910 (11.8%) | −251.7 | −248.9 | 0.41 |
| ESR1 SRX7624157 | MCF-7 Breast | 1120 / 21491 (5.2%) | 26250 / 214910 (12.2%) | −246.4 | −243.6 | 0.43 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 613 / 21491 (2.9%) | 854 / 214910 (0.4%) | −244.9 | −242.2 | 7.18 |
| MEAF6 DRX300417 | 293 Kidney | 2016 / 21491 (9.4%) | 8317 / 214910 (3.9%) | −244.3 | −241.5 | 2.42 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 817 / 21491 (3.8%) | 1652 / 214910 (0.8%) | −244.1 | −241.4 | 4.95 |
| TP53 SRX19538273 | U2OS Bone | 380 / 21491 (1.8%) | 201 / 214910 (0.1%) | −244.0 | −241.2 | 18.91 |
| TP53 SRX19538275 | U2OS Bone | 386 / 21491 (1.8%) | 220 / 214910 (0.1%) | −241.3 | −238.6 | 17.55 |
| ESR1 SRX4367193 | MCF-7 Breast | 1420 / 21491 (6.6%) | 30216 / 214910 (14.1%) | −240.9 | −238.1 | 0.47 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 826 / 21491 (3.8%) | 1717 / 214910 (0.8%) | −240.7 | −237.9 | 4.81 |
| TP53 SRX19538281 | Osteoblasts Bone | 446 / 21491 (2.1%) | 377 / 214910 (0.2%) | −236.6 | −233.9 | 11.83 |
| ESR1 SRX371478 | MCF-7 Breast | 570 / 21491 (2.7%) | 17588 / 214910 (8.2%) | −236.3 | −233.6 | 0.32 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1076 / 21491 (5.0%) | 25200 / 214910 (11.7%) | −235.3 | −232.6 | 0.43 |
| ESR1 SRX176860 | MCF-7 Breast | 721 / 21491 (3.4%) | 19939 / 214910 (9.3%) | −235.3 | −232.6 | 0.36 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 316 / 21491 (1.5%) | 13184 / 214910 (6.1%) | −234.7 | −232.0 | 0.24 |
| YAP1 SRX757325 | H2052 Lung | 1148 / 21491 (5.3%) | 26175 / 214910 (12.2%) | −234.1 | −231.4 | 0.44 |
| ESR1 SRX20282961 | MCF-7 Breast | 559 / 21491 (2.6%) | 17328 / 214910 (8.1%) | −233.9 | −231.2 | 0.32 |
| FOXA1 SRX1161177 | MCF-7 Breast | 452 / 21491 (2.1%) | 15467 / 214910 (7.2%) | −231.3 | −228.6 | 0.29 |
| LEO1 SRX1873456 | SEM Blood | 1854 / 21491 (8.6%) | 7564 / 214910 (3.5%) | −228.4 | −225.8 | 2.45 |
| ESR1 SRX7624156 | MCF-7 Breast | 718 / 21491 (3.3%) | 19641 / 214910 (9.1%) | −228.2 | −225.6 | 0.37 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1154 / 21491 (5.4%) | 3437 / 214910 (1.6%) | −227.8 | −225.1 | 3.36 |
| ESR1 SRX176861 | MCF-7 Breast | 743 / 21491 (3.5%) | 20005 / 214910 (9.3%) | −227.7 | −225.0 | 0.37 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 316 / 21491 (1.5%) | 12964 / 214910 (6.0%) | −227.6 | −225.0 | 0.24 |
| ESR1 SRX371469 | MCF-7 Breast | 468 / 21491 (2.2%) | 15607 / 214910 (7.3%) | −227.2 | −224.5 | 0.30 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1065 / 21491 (5.0%) | 24659 / 214910 (11.5%) | −225.3 | −222.7 | 0.43 |
| ESR1 SRX20282939 | MCF-7 Breast | 518 / 21491 (2.4%) | 16251 / 214910 (7.6%) | −221.6 | −219.0 | 0.32 |
| FOXA1 SRX371481 | MCF-7 Breast | 495 / 21491 (2.3%) | 15822 / 214910 (7.4%) | −220.0 | −217.4 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 523 / 21491 (2.4%) | 16253 / 214910 (7.6%) | −219.3 | −216.7 | 0.32 |
| ESR1 SRX1531791 | MCF-7 Breast | 440 / 21491 (2.0%) | 14822 / 214910 (6.9%) | −217.6 | −215.0 | 0.30 |
| YAP1 SRX757326 | H2052 Lung | 1004 / 21491 (4.7%) | 23429 / 214910 (10.9%) | −216.0 | −213.4 | 0.43 |
| TP53 SRX19538269 | U2OS Bone | 475 / 21491 (2.2%) | 545 / 214910 (0.3%) | −214.4 | −211.8 | 8.72 |
| FOXA1 SRX371483 | MCF-7 Breast | 541 / 21491 (2.5%) | 16314 / 214910 (7.6%) | −212.4 | −209.8 | 0.33 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1388 / 21491 (6.5%) | 28601 / 214910 (13.3%) | −212.0 | −209.4 | 0.49 |
| ESR1 SRX371479 | MCF-7 Breast | 438 / 21491 (2.0%) | 14596 / 214910 (6.8%) | −211.7 | −209.1 | 0.30 |
| JADE3 DRX300415 | 293 Kidney | 1920 / 21491 (8.9%) | 8320 / 214910 (3.9%) | −210.9 | −208.4 | 2.31 |
| FOXA1 SRX1161176 | MCF-7 Breast | 457 / 21491 (2.1%) | 14880 / 214910 (6.9%) | −210.6 | −208.1 | 0.31 |
| FOS SRX4192880 | MCF 10A Breast | 815 / 21491 (3.8%) | 20460 / 214910 (9.5%) | −210.4 | −207.8 | 0.40 |
| GATA3 SRX190239 | MCF-7 Breast | 706 / 21491 (3.3%) | 18739 / 214910 (8.7%) | −208.1 | −205.5 | 0.38 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 1025 / 21491 (4.8%) | 2984 / 214910 (1.4%) | −207.8 | −205.3 | 3.43 |
| TLE3 SRX4815191 | MCF-7 Breast | 467 / 21491 (2.2%) | 14948 / 214910 (7.0%) | −207.7 | −205.2 | 0.31 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1132 / 21491 (5.3%) | 24897 / 214910 (11.6%) | −207.4 | −204.8 | 0.45 |
| AR SRX10820653 | LNCAP Prostate | 356 / 21491 (1.7%) | 244 / 214910 (0.1%) | −207.2 | −204.7 | 14.59 |
| FOXA1 SRX371482 | MCF-7 Breast | 703 / 21491 (3.3%) | 18665 / 214910 (8.7%) | −207.2 | −204.7 | 0.38 |
| FOXA1 SRX1161173 | MCF-7 Breast | 383 / 21491 (1.8%) | 13483 / 214910 (6.3%) | −206.1 | −203.6 | 0.28 |
| FOXA1 SRX3931044 | MCF-7 Breast | 1032 / 21491 (4.8%) | 23438 / 214910 (10.9%) | −206.1 | −203.5 | 0.44 |
| ESR1 SRX20282972 | MCF-7 Breast | 531 / 21491 (2.5%) | 15933 / 214910 (7.4%) | −206.0 | −203.5 | 0.33 |
| ESR1 SRX20282954 | MCF-7 Breast | 519 / 21491 (2.4%) | 15734 / 214910 (7.3%) | −205.8 | −203.3 | 0.33 |
| ESR1 SRX371467 | MCF-7 Breast | 504 / 21491 (2.3%) | 15487 / 214910 (7.2%) | −205.7 | −203.2 | 0.33 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 927 / 21491 (4.3%) | 21904 / 214910 (10.2%) | −205.1 | −202.6 | 0.42 |
| ESR1 SRX194572 | MCF-7 Breast | 295 / 21491 (1.4%) | 11892 / 214910 (5.5%) | −205.0 | −202.5 | 0.25 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 566 / 21491 (2.6%) | 16432 / 214910 (7.6%) | −204.3 | −201.8 | 0.34 |
| FOS SRX150517 | MCF 10A Breast | 832 / 21491 (3.9%) | 20482 / 214910 (9.5%) | −204.2 | −201.7 | 0.41 |
| ESR1 SRX194569 | MCF-7 Breast | 504 / 21491 (2.3%) | 15430 / 214910 (7.2%) | −204.1 | −201.6 | 0.33 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1253 / 21491 (5.8%) | 26413 / 214910 (12.3%) | −203.6 | −201.1 | 0.47 |
| ESR1 SRX10365535 | MCF-7 Breast | 377 / 21491 (1.8%) | 13242 / 214910 (6.2%) | −201.9 | −199.4 | 0.28 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 468 / 21491 (2.2%) | 14751 / 214910 (6.9%) | −201.3 | −198.8 | 0.32 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 579 / 21491 (2.7%) | 16524 / 214910 (7.7%) | −201.0 | −198.5 | 0.35 |
| ESR1 SRX371468 | MCF-7 Breast | 306 / 21491 (1.4%) | 11959 / 214910 (5.6%) | −200.8 | −198.3 | 0.26 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 628 / 21491 (2.9%) | 1186 / 214910 (0.6%) | −198.9 | −196.5 | 5.30 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 709 / 21491 (3.3%) | 18409 / 214910 (8.6%) | −197.7 | −195.3 | 0.39 |
| IRF3 SRX11453858 | Hep G2 Liver | 282 / 21491 (1.3%) | 114 / 214910 (0.1%) | −197.2 | −194.7 | 24.74 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 668 / 21491 (3.1%) | 1370 / 214910 (0.6%) | −196.7 | −194.2 | 4.88 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 1087 / 21491 (5.1%) | 23841 / 214910 (11.1%) | −196.7 | −194.2 | 0.46 |
| ESR1 SRX10365536 | MCF-7 Breast | 249 / 21491 (1.2%) | 10788 / 214910 (5.0%) | −196.6 | −194.2 | 0.23 |
| FOXA1 SRX1161175 | MCF-7 Breast | 373 / 21491 (1.7%) | 12974 / 214910 (6.0%) | −195.7 | −193.3 | 0.29 |
| TP53 SRX19538270 | U2OS Bone | 443 / 21491 (2.1%) | 527 / 214910 (0.2%) | −195.7 | −193.2 | 8.41 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1892 / 21491 (8.8%) | 8444 / 214910 (3.9%) | −195.5 | −193.1 | 2.24 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 453 / 21491 (2.1%) | 14301 / 214910 (6.7%) | −195.3 | −192.8 | 0.32 |
| ESR1 SRX371476 | MCF-7 Breast | 372 / 21491 (1.7%) | 12921 / 214910 (6.0%) | −194.6 | −192.2 | 0.29 |
| Epitope tags SRX10549778 | K-562 Blood | 1374 / 21491 (6.4%) | 5147 / 214910 (2.4%) | −194.3 | −191.9 | 2.67 |
| GATA3 SRX5057632 | MCF-7 Breast | 320 / 21491 (1.5%) | 11999 / 214910 (5.6%) | −194.1 | −191.7 | 0.27 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 1065 / 21491 (5.0%) | 23419 / 214910 (10.9%) | −193.9 | −191.5 | 0.45 |
| STAT1 SRX23678708 | K-562 Blood | 1886 / 21491 (8.8%) | 8441 / 214910 (3.9%) | −193.6 | −191.2 | 2.23 |
| GATA3 SRX176864 | MCF-7 Breast | 367 / 21491 (1.7%) | 12787 / 214910 (5.9%) | −193.0 | −190.6 | 0.29 |
| JADE3 DRX234809 | 293 Kidney | 1269 / 21491 (5.9%) | 4547 / 214910 (2.1%) | −192.5 | −190.1 | 2.79 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 943 / 21491 (4.4%) | 2729 / 214910 (1.3%) | −192.4 | −190.0 | 3.46 |
| ESR1 SRX20282955 | MCF-7 Breast | 520 / 21491 (2.4%) | 15280 / 214910 (7.1%) | −192.1 | −189.7 | 0.34 |
| BRD4 SRX736204 | 90-8TL Neural | 1107 / 21491 (5.2%) | 3622 / 214910 (1.7%) | −192.0 | −189.6 | 3.06 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 727 / 21491 (3.4%) | 18451 / 214910 (8.6%) | −191.5 | −189.1 | 0.39 |
| FOXA1 SRX371480 | MCF-7 Breast | 340 / 21491 (1.6%) | 12263 / 214910 (5.7%) | −191.4 | −189.0 | 0.28 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 816 / 21491 (3.8%) | 19701 / 214910 (9.2%) | −189.8 | −187.4 | 0.41 |
| SS18 SRX3468047 | Fibroblasts Others | 1244 / 21491 (5.8%) | 25703 / 214910 (12.0%) | −189.5 | −187.1 | 0.48 |
| YAP1 SRX5718140 | 293 Kidney | 858 / 21491 (4.0%) | 20262 / 214910 (9.4%) | −188.5 | −186.2 | 0.42 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 864 / 21491 (4.0%) | 20336 / 214910 (9.5%) | −188.2 | −185.8 | 0.42 |
| ESR1 SRX20282973 | MCF-7 Breast | 604 / 21491 (2.8%) | 16455 / 214910 (7.7%) | −188.1 | −185.7 | 0.37 |
| ESR1 SRX4367192 | MCF-7 Breast | 1010 / 21491 (4.7%) | 22380 / 214910 (10.4%) | −187.2 | −184.9 | 0.45 |
| ESR1 SRX371471 | ZR-75-1 Breast | 565 / 21491 (2.6%) | 15798 / 214910 (7.4%) | −186.6 | −184.3 | 0.36 |
| TCF12 SRX190356 | SK-N-SH Neural | 1342 / 21491 (6.2%) | 26898 / 214910 (12.5%) | −186.5 | −184.1 | 0.50 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1758 / 21491 (8.2%) | 32322 / 214910 (15.0%) | −186.1 | −183.7 | 0.54 |
| FOXA1 SRX3923514 | MCF-7 Breast | 519 / 21491 (2.4%) | 15031 / 214910 (7.0%) | −185.5 | −183.1 | 0.35 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 465 / 21491 (2.2%) | 14138 / 214910 (6.6%) | −184.7 | −182.3 | 0.33 |
| FOXA1 SRX1161174 | MCF-7 Breast | 533 / 21491 (2.5%) | 15227 / 214910 (7.1%) | −184.6 | −182.2 | 0.35 |
| GATA3 SRX190194 | SK-N-SH Neural | 1180 / 21491 (5.5%) | 24622 / 214910 (11.5%) | −184.5 | −182.2 | 0.48 |
| EP300 ERX626811 | U-937 Blood | 1496 / 21491 (7.0%) | 6078 / 214910 (2.8%) | −184.1 | −181.8 | 2.46 |
| STAT1 SRX23678707 | K-562 Blood | 1750 / 21491 (8.1%) | 7729 / 214910 (3.6%) | −184.1 | −181.7 | 2.26 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 473 / 21491 (2.2%) | 14231 / 214910 (6.6%) | −183.6 | −181.3 | 0.33 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1888 / 21491 (8.8%) | 33856 / 214910 (15.8%) | −183.5 | −181.1 | 0.56 |
| EP300 ERX626821 | U-937 Blood | 1491 / 21491 (6.9%) | 6062 / 214910 (2.8%) | −183.3 | −180.9 | 2.46 |
| ESR1 SRX2881000 | MCF-7 Breast | 442 / 21491 (2.1%) | 13697 / 214910 (6.4%) | −182.7 | −180.3 | 0.32 |
| SSRP1 SRX3436567 | HT-1080 Bone | 471 / 21491 (2.2%) | 689 / 214910 (0.3%) | −181.8 | −179.5 | 6.84 |
| FOXA1 SRX100454 | T-47D Breast | 672 / 21491 (3.1%) | 17238 / 214910 (8.0%) | −181.1 | −178.8 | 0.39 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 889 / 21491 (4.1%) | 2576 / 214910 (1.2%) | −180.9 | −178.6 | 3.45 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1666 / 21491 (7.8%) | 30901 / 214910 (14.4%) | −180.9 | −178.6 | 0.54 |
| ESR1 SRX10365532 | MCF-7 Breast | 274 / 21491 (1.3%) | 10751 / 214910 (5.0%) | −180.6 | −178.2 | 0.25 |
| KAT7 DRX234808 | 293 Kidney | 934 / 21491 (4.3%) | 2821 / 214910 (1.3%) | −180.3 | −178.0 | 3.31 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 278 / 21491 (1.3%) | 143 / 214910 (0.1%) | −180.3 | −177.9 | 19.44 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 409 / 21491 (1.9%) | 13070 / 214910 (6.1%) | −180.3 | −177.9 | 0.31 |
| ESR1 SRX2881002 | MCF-7 Breast | 484 / 21491 (2.3%) | 14282 / 214910 (6.6%) | −180.0 | −177.7 | 0.34 |
| FOS SRX150476 | MCF 10A Breast | 895 / 21491 (4.2%) | 20444 / 214910 (9.5%) | −179.7 | −177.3 | 0.44 |
| ESR1 SRX371470 | ZR-75-1 Breast | 491 / 21491 (2.3%) | 14376 / 214910 (6.7%) | −179.4 | −177.1 | 0.34 |
| ESR1 SRX20282940 | MCF-7 Breast | 563 / 21491 (2.6%) | 15485 / 214910 (7.2%) | −178.7 | −176.3 | 0.36 |
| FOXA1 SRX11222441 | MCF-7 Breast | 401 / 21491 (1.9%) | 12875 / 214910 (6.0%) | −178.3 | −176.0 | 0.31 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 797 / 21491 (3.7%) | 2138 / 214910 (1.0%) | −177.9 | −175.6 | 3.73 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 443 / 21491 (2.1%) | 13536 / 214910 (6.3%) | −177.4 | −175.1 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 281 / 21491 (1.3%) | 10768 / 214910 (5.0%) | −177.1 | −174.8 | 0.26 |
| FOXA1 SRX028634 | MCF-7 Breast | 255 / 21491 (1.2%) | 10295 / 214910 (4.8%) | −176.9 | −174.6 | 0.25 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 945 / 21491 (4.4%) | 2922 / 214910 (1.4%) | −176.9 | −174.6 | 3.23 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 373 / 21491 (1.7%) | 12351 / 214910 (5.7%) | −176.7 | −174.4 | 0.30 |
| RAC1 SRX10365541 | MCF-7 Breast | 284 / 21491 (1.3%) | 10808 / 214910 (5.0%) | −176.6 | −174.3 | 0.26 |
| MEN1 SRX11712604 | K-562 Blood | 1691 / 21491 (7.9%) | 7490 / 214910 (3.5%) | −176.6 | −174.3 | 2.26 |
| ESR1 SRX10365558 | MCF-7 Breast | 344 / 21491 (1.6%) | 11836 / 214910 (5.5%) | −175.9 | −173.6 | 0.29 |
| JUN SRX17561461 | LPS141 Adipocyte | 758 / 21491 (3.5%) | 18313 / 214910 (8.5%) | −175.8 | −173.5 | 0.41 |
| FOXA1 SRX11222437 | MCF-7 Breast | 379 / 21491 (1.8%) | 12420 / 214910 (5.8%) | −175.7 | −173.4 | 0.31 |
| LARP7 SRX2198835 | HeLa Uterus | 2534 / 21491 (11.8%) | 13510 / 214910 (6.3%) | −174.1 | −171.8 | 1.88 |
| AR SRX10820651 | LNCAP Prostate | 367 / 21491 (1.7%) | 388 / 214910 (0.2%) | −173.6 | −171.3 | 9.46 |
| JUNB SRX8488088 | SUM 229PE Breast | 1006 / 21491 (4.7%) | 21757 / 214910 (10.1%) | −173.4 | −171.1 | 0.46 |
| FOXA1 SRX028635 | MCF-7 Breast | 258 / 21491 (1.2%) | 10238 / 214910 (4.8%) | −173.3 | −171.1 | 0.25 |
| TP53 SRX19538282 | Osteoblasts Bone | 370 / 21491 (1.7%) | 401 / 214910 (0.2%) | −172.6 | −170.3 | 9.23 |
| TLE3 SRX4815192 | MCF-7 Breast | 481 / 21491 (2.2%) | 13967 / 214910 (6.5%) | −172.3 | −170.1 | 0.34 |
| ESR1 SRX371477 | MCF-7 Breast | 268 / 21491 (1.2%) | 10363 / 214910 (4.8%) | −171.5 | −169.3 | 0.26 |
| ARID1A SRX5089376 | MCF-7 Breast | 471 / 21491 (2.2%) | 13750 / 214910 (6.4%) | −170.7 | −168.4 | 0.34 |
| FOXA2 SRX3230382 | Hep G2 Liver | 722 / 21491 (3.4%) | 17587 / 214910 (8.2%) | −170.6 | −168.4 | 0.41 |
| FOXA1 SRX5323843 | MCF-7 Breast | 274 / 21491 (1.3%) | 10435 / 214910 (4.9%) | −170.5 | −168.2 | 0.26 |
| FOS SRX4192879 | MCF 10A Breast | 623 / 21491 (2.9%) | 16091 / 214910 (7.5%) | −170.2 | −168.0 | 0.39 |
| FOXA1 SRX1787653 | MCF-7 Breast | 444 / 21491 (2.1%) | 13282 / 214910 (6.2%) | −169.7 | −167.4 | 0.33 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 699 / 21491 (3.3%) | 17180 / 214910 (8.0%) | −168.9 | −166.7 | 0.41 |
| ING2 SRX286201 | RKO Digestive tract | 1673 / 21491 (7.8%) | 7536 / 214910 (3.5%) | −168.6 | −166.4 | 2.22 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 546 / 21491 (2.5%) | 14849 / 214910 (6.9%) | −168.3 | −166.1 | 0.37 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1603 / 21491 (7.5%) | 7076 / 214910 (3.3%) | −168.2 | −165.9 | 2.27 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 381 / 21491 (1.8%) | 12178 / 214910 (5.7%) | −167.6 | −165.3 | 0.31 |
| FOXA1 SRX100506 | Hep G2 Liver | 714 / 21491 (3.3%) | 17348 / 214910 (8.1%) | −167.5 | −165.2 | 0.41 |
| FOXA1 SRX11222442 | MCF-7 Breast | 363 / 21491 (1.7%) | 11873 / 214910 (5.5%) | −167.3 | −165.1 | 0.31 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1698 / 21491 (7.9%) | 30639 / 214910 (14.3%) | −166.6 | −164.3 | 0.55 |
| RUNX1 SRX2513054 | 293 Kidney | 3678 / 21491 (17.1%) | 22641 / 214910 (10.5%) | −166.5 | −164.3 | 1.62 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1679 / 21491 (7.8%) | 7621 / 214910 (3.5%) | −166.5 | −164.2 | 2.20 |
| ESR1 SRX20282971 | MCF-7 Breast | 531 / 21491 (2.5%) | 14548 / 214910 (6.8%) | −166.4 | −164.2 | 0.36 |
| FOXA1 SRX3923517 | MCF-7 Breast | 382 / 21491 (1.8%) | 12157 / 214910 (5.7%) | −166.4 | −164.2 | 0.31 |
| ESR1 SRX330067 | MCF-7 Breast | 490 / 21491 (2.3%) | 13888 / 214910 (6.5%) | −166.0 | −163.8 | 0.35 |
| GATA3 SRX6712581 | MCF-7 Breast | 449 / 21491 (2.1%) | 13225 / 214910 (6.2%) | −165.7 | −163.5 | 0.34 |
| FOXA1 SRX3923516 | MCF-7 Breast | 390 / 21491 (1.8%) | 12260 / 214910 (5.7%) | −165.6 | −163.4 | 0.32 |
| FOXA1 SRX1787651 | MCF-7 Breast | 310 / 21491 (1.4%) | 10911 / 214910 (5.1%) | −165.6 | −163.4 | 0.28 |
| IRF3 SRX11453861 | Hep G2 Liver | 246 / 21491 (1.1%) | 113 / 214910 (0.1%) | −165.6 | −163.4 | 21.77 |
| ESR1 SRX2943591 | MCF-7 Breast | 388 / 21491 (1.8%) | 12219 / 214910 (5.7%) | −165.3 | −163.1 | 0.32 |
| ESR1 SRX4451213 | MCF-7 Breast | 547 / 21491 (2.5%) | 14742 / 214910 (6.9%) | −165.1 | −162.9 | 0.37 |
| ESR1 SRX20282946 | MCF-7 Breast | 329 / 21491 (1.5%) | 11218 / 214910 (5.2%) | −165.0 | −162.8 | 0.29 |
| AR SRX9469988 | LAPC-4 Prostate | 713 / 21491 (3.3%) | 17234 / 214910 (8.0%) | −165.0 | −162.8 | 0.41 |
| EP300 SRX100540 | SK-N-SH Neural | 772 / 21491 (3.6%) | 18096 / 214910 (8.4%) | −164.9 | −162.7 | 0.43 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1882 / 21491 (8.8%) | 9051 / 214910 (4.2%) | −164.8 | −162.6 | 2.08 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 201 / 21491 (0.9%) | 8910 / 214910 (4.1%) | −164.6 | −162.4 | 0.23 |
| STAT5B SRX831881 | CD8+ T cells Blood | 274 / 21491 (1.3%) | 174 / 214910 (0.1%) | −164.6 | −162.4 | 15.75 |
| JUNB SRX8488073 | SUM 229PE Breast | 1001 / 21491 (4.7%) | 21316 / 214910 (9.9%) | −164.5 | −162.3 | 0.47 |
| ESR1 SRX330069 | MCF-7 Breast | 335 / 21491 (1.6%) | 11304 / 214910 (5.3%) | −164.5 | −162.3 | 0.30 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1560 / 21491 (7.3%) | 6867 / 214910 (3.2%) | −164.5 | −162.3 | 2.27 |
| ESR1 SRX20282953 | MCF-7 Breast | 445 / 21491 (2.1%) | 13116 / 214910 (6.1%) | −164.4 | −162.2 | 0.34 |
| FOXA1 SRX3931043 | MCF-7 Breast | 559 / 21491 (2.6%) | 14869 / 214910 (6.9%) | −163.5 | −161.3 | 0.38 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 1023 / 21491 (4.8%) | 3535 / 214910 (1.6%) | −163.4 | −161.3 | 2.89 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 808 / 21491 (3.8%) | 18553 / 214910 (8.6%) | −163.4 | −161.2 | 0.44 |
| AR SRX1067071 | LHSAR Prostate | 1050 / 21491 (4.9%) | 21933 / 214910 (10.2%) | −163.1 | −160.9 | 0.48 |
| 5-mC SRX882970 | LNCAP Prostate | 3261 / 21491 (15.2%) | 19443 / 214910 (9.0%) | −162.8 | −160.7 | 1.68 |
| FOXA2 SRX100448 | Hep G2 Liver | 610 / 21491 (2.8%) | 15587 / 214910 (7.3%) | −161.9 | −159.7 | 0.39 |
| FOXA1 SRX100477 | Hep G2 Liver | 627 / 21491 (2.9%) | 15836 / 214910 (7.4%) | −161.7 | −159.6 | 0.40 |
| ESR1 SRX3110725 | MCF-7 Breast | 497 / 21491 (2.3%) | 13838 / 214910 (6.4%) | −161.5 | −159.4 | 0.36 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 1323 / 21491 (6.2%) | 25519 / 214910 (11.9%) | −161.2 | −159.0 | 0.52 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 517 / 21491 (2.4%) | 14133 / 214910 (6.6%) | −161.0 | −158.9 | 0.37 |
| FOXA1 SRX11222438 | MCF-7 Breast | 301 / 21491 (1.4%) | 10594 / 214910 (4.9%) | −160.5 | −158.4 | 0.28 |
| FOXA1 SRX1787655 | MCF-7 Breast | 284 / 21491 (1.3%) | 10281 / 214910 (4.8%) | −160.0 | −157.8 | 0.28 |
| JUN SRX6582171 | GM07492 Others | 1039 / 21491 (4.8%) | 21636 / 214910 (10.1%) | −159.7 | −157.5 | 0.48 |
| ESR1 SRX10365533 | MCF-7 Breast | 269 / 21491 (1.3%) | 9982 / 214910 (4.6%) | −159.0 | −156.9 | 0.27 |
| FOXA1 SRX3923518 | MCF-7 Breast | 385 / 21491 (1.8%) | 11955 / 214910 (5.6%) | −159.0 | −156.8 | 0.32 |
| CDK9 SRX7366783 | MCF-7 Breast | 264 / 21491 (1.2%) | 167 / 214910 (0.1%) | −158.8 | −156.7 | 15.81 |
| EP300 SRX176885 | MCF-7 Breast | 294 / 21491 (1.4%) | 10405 / 214910 (4.8%) | −158.6 | −156.4 | 0.28 |
| SMARCA4 SRX5212362 | Mel270 Others | 939 / 21491 (4.4%) | 20201 / 214910 (9.4%) | −158.4 | −156.2 | 0.46 |
| ESR1 SRX2912055 | MCF-7 Breast | 212 / 21491 (1.0%) | 8924 / 214910 (4.2%) | −158.3 | −156.1 | 0.24 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 150 / 21491 (0.7%) | 7725 / 214910 (3.6%) | −158.1 | −156.0 | 0.19 |
| 5-mC SRX882968 | LNCAP Prostate | 3218 / 21491 (15.0%) | 19270 / 214910 (9.0%) | −158.0 | −155.8 | 1.67 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2319 / 21491 (10.8%) | 12372 / 214910 (5.8%) | −157.9 | −155.8 | 1.87 |
| ESR1 SRX1531796 | MCF-7 Breast | 295 / 21491 (1.4%) | 10400 / 214910 (4.8%) | −157.8 | −155.7 | 0.28 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 461 / 21491 (2.1%) | 13135 / 214910 (6.1%) | −157.8 | −155.6 | 0.35 |
| NANOG SRX10445309 | Neural crest cells Neural | 301 / 21491 (1.4%) | 10499 / 214910 (4.9%) | −157.7 | −155.6 | 0.29 |
| ESR1 SRX8537722 | MCF-7 Breast | 518 / 21491 (2.4%) | 14023 / 214910 (6.5%) | −157.7 | −155.5 | 0.37 |
| ESR1 SRX371475 | BT-474 Breast | 295 / 21491 (1.4%) | 10388 / 214910 (4.8%) | −157.5 | −155.4 | 0.28 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 530 / 21491 (2.5%) | 14165 / 214910 (6.6%) | −156.4 | −154.3 | 0.37 |
| FOXA1 SRX3931055 | MCF-7 Breast | 481 / 21491 (2.2%) | 13399 / 214910 (6.2%) | −156.3 | −154.1 | 0.36 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 611 / 21491 (2.8%) | 15387 / 214910 (7.2%) | −156.2 | −154.1 | 0.40 |
| ARID5B SRX3230377 | Hep G2 Liver | 1337 / 21491 (6.2%) | 25479 / 214910 (11.9%) | −156.2 | −154.1 | 0.52 |
| FOXA1 SRX3923519 | MCF-7 Breast | 349 / 21491 (1.6%) | 11247 / 214910 (5.2%) | −155.8 | −153.6 | 0.31 |
| ESR1 SRX330070 | MCF-7 Breast | 297 / 21491 (1.4%) | 10367 / 214910 (4.8%) | −155.8 | −153.6 | 0.29 |
| FOXA1 SRX1787652 | MCF-7 Breast | 352 / 21491 (1.6%) | 11291 / 214910 (5.3%) | −155.6 | −153.4 | 0.31 |
| ESR1 SRX20282938 | MCF-7 Breast | 453 / 21491 (2.1%) | 12925 / 214910 (6.0%) | −155.4 | −153.3 | 0.35 |
| NR3C1 SRX2609664 | HASM2 Lung | 779 / 21491 (3.6%) | 17814 / 214910 (8.3%) | −155.3 | −153.2 | 0.44 |
| FOXA1 SRX3931054 | MCF-7 Breast | 533 / 21491 (2.5%) | 14159 / 214910 (6.6%) | −155.0 | −152.9 | 0.38 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 285 / 21491 (1.3%) | 10127 / 214910 (4.7%) | −154.8 | −152.7 | 0.28 |
| ESR1 SRX5323873 | MCF-7 Breast | 684 / 21491 (3.2%) | 16402 / 214910 (7.6%) | −154.5 | −152.4 | 0.42 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 573 / 21491 (2.7%) | 14744 / 214910 (6.9%) | −154.4 | −152.3 | 0.39 |
| ESR1 SRX371474 | BT-474 Breast | 272 / 21491 (1.3%) | 9882 / 214910 (4.6%) | −154.3 | −152.2 | 0.28 |
| FOXA1 SRX5323845 | MCF-7 Breast | 210 / 21491 (1.0%) | 8743 / 214910 (4.1%) | −153.6 | −151.4 | 0.24 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1675 / 21491 (7.8%) | 29702 / 214910 (13.8%) | −153.3 | −151.2 | 0.56 |
| BMI1 SRX644729 | 293 Kidney | 254 / 21491 (1.2%) | 160 / 214910 (0.1%) | −153.1 | −151.0 | 15.88 |
| FOXA1 SRX3923515 | MCF-7 Breast | 321 / 21491 (1.5%) | 10683 / 214910 (5.0%) | −152.9 | −150.8 | 0.30 |
| CEBPA SRX2630241 | Hep G2 Liver | 689 / 21491 (3.2%) | 16401 / 214910 (7.6%) | −152.6 | −150.5 | 0.42 |
| ESR1 SRX11120903 | MCF-7 Breast | 492 / 21491 (2.3%) | 13405 / 214910 (6.2%) | −151.7 | −149.6 | 0.37 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 736 / 21491 (3.4%) | 17049 / 214910 (7.9%) | −151.7 | −149.6 | 0.43 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 627 / 21491 (2.9%) | 15453 / 214910 (7.2%) | −151.7 | −149.6 | 0.41 |
| FOXA1 SRX1447317 | MCF-7 Breast | 381 / 21491 (1.8%) | 11637 / 214910 (5.4%) | −151.7 | −149.6 | 0.33 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1941 / 21491 (9.0%) | 9787 / 214910 (4.6%) | −151.7 | −149.6 | 1.98 |
| ESR1 SRX4451212 | MCF-7 Breast | 538 / 21491 (2.5%) | 14106 / 214910 (6.6%) | −151.5 | −149.4 | 0.38 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 655 / 21491 (3.0%) | 1702 / 214910 (0.8%) | −151.4 | −149.3 | 3.85 |
| CDK9 SRX7366781 | MCF-7 Breast | 248 / 21491 (1.2%) | 151 / 214910 (0.1%) | −151.4 | −149.3 | 16.42 |
| JUNB SRX4192882 | MCF 10A Breast | 468 / 21491 (2.2%) | 13021 / 214910 (6.1%) | −151.4 | −149.3 | 0.36 |
| ESR1 SRX1012629 | MCF-7 Breast | 368 / 21491 (1.7%) | 11408 / 214910 (5.3%) | −151.2 | −149.2 | 0.32 |
| ESR1 SRX2943589 | MCF-7 Breast | 301 / 21491 (1.4%) | 10283 / 214910 (4.8%) | −151.1 | −149.0 | 0.29 |
| TP53 SRX19538271 | U2OS Bone | 631 / 21491 (2.9%) | 1589 / 214910 (0.7%) | −151.1 | −149.0 | 3.97 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1865 / 21491 (8.7%) | 31975 / 214910 (14.9%) | −151.0 | −148.9 | 0.58 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 731 / 21491 (3.4%) | 16944 / 214910 (7.9%) | −150.9 | −148.8 | 0.43 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 529 / 21491 (2.5%) | 13939 / 214910 (6.5%) | −150.8 | −148.7 | 0.38 |
| SMARCA4 SRX5212357 | Mel270 Others | 821 / 21491 (3.8%) | 18218 / 214910 (8.5%) | −150.6 | −148.6 | 0.45 |
| FOXA1 SRX1447316 | MCF-7 Breast | 250 / 21491 (1.2%) | 9351 / 214910 (4.4%) | −149.8 | −147.8 | 0.27 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 294 / 21491 (1.4%) | 10118 / 214910 (4.7%) | −149.8 | −147.7 | 0.29 |
| ESR1 SRX1469949 | MCF-7 Breast | 336 / 21491 (1.6%) | 10826 / 214910 (5.0%) | −149.6 | −147.5 | 0.31 |
| FOXA1 SRX5203303 | MCF-7 Breast | 201 / 21491 (0.9%) | 8453 / 214910 (3.9%) | −149.5 | −147.4 | 0.24 |
| GATAD2A SRX2636506 | Hep G2 Liver | 730 / 21491 (3.4%) | 16870 / 214910 (7.8%) | −149.4 | −147.3 | 0.43 |
| SMARCA4 SRX5212366 | Mel270 Others | 770 / 21491 (3.6%) | 17435 / 214910 (8.1%) | −149.2 | −147.1 | 0.44 |
| SOX13 SRX2636248 | Hep G2 Liver | 780 / 21491 (3.6%) | 17574 / 214910 (8.2%) | −149.1 | −147.1 | 0.44 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 604 / 21491 (2.8%) | 15005 / 214910 (7.0%) | −149.0 | −146.9 | 0.40 |
| NR2F2 SRX190293 | MCF-7 Breast | 609 / 21491 (2.8%) | 15076 / 214910 (7.0%) | −148.9 | −146.9 | 0.40 |
| MYC SRX13134693 | 293 Kidney | 1518 / 21491 (7.1%) | 6922 / 214910 (3.2%) | −148.3 | −146.2 | 2.19 |
| ESR1 SRX3123829 | MCF-7 Breast | 342 / 21491 (1.6%) | 10872 / 214910 (5.1%) | −148.1 | −146.0 | 0.31 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1383 / 21491 (6.4%) | 6030 / 214910 (2.8%) | −148.0 | −145.9 | 2.29 |
| FOXA1 SRX15430999 | T-47D Breast | 643 / 21491 (3.0%) | 15536 / 214910 (7.2%) | −147.7 | −145.6 | 0.41 |
| ESR1 SRX8537723 | MCF-7 Breast | 471 / 21491 (2.2%) | 12930 / 214910 (6.0%) | −147.7 | −145.6 | 0.36 |
| KAT7 DRX300414 | 293 Kidney | 702 / 21491 (3.3%) | 1978 / 214910 (0.9%) | −147.6 | −145.5 | 3.55 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 211 / 21491 (1.0%) | 8579 / 214910 (4.0%) | −147.6 | −145.5 | 0.25 |
| SMARCA2 SRX8119677 | MeT-5A Others | 926 / 21491 (4.3%) | 19561 / 214910 (9.1%) | −147.5 | −145.5 | 0.47 |
| ESR1 SRX5323871 | MCF-7 Breast | 629 / 21491 (2.9%) | 15314 / 214910 (7.1%) | −147.3 | −145.2 | 0.41 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1841 / 21491 (8.6%) | 9192 / 214910 (4.3%) | −147.1 | −145.1 | 2.00 |
| ESR1 SRX2513520 | MCF-7 Breast | 366 / 21491 (1.7%) | 11233 / 214910 (5.2%) | −147.1 | −145.0 | 0.33 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 402 / 21491 (1.9%) | 11816 / 214910 (5.5%) | −147.0 | −144.9 | 0.34 |
| JUNB SRX10119386 | MCF 10A Breast | 535 / 21491 (2.5%) | 13881 / 214910 (6.5%) | −146.8 | −144.7 | 0.39 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1412 / 21491 (6.6%) | 6253 / 214910 (2.9%) | −146.5 | −144.4 | 2.26 |
| Epitope tags SRX5877912 | U2OS Bone | 2920 / 21491 (13.6%) | 44445 / 214910 (20.7%) | −146.4 | −144.4 | 0.66 |
| FOXA1 SRX6878603 | LNCAP Prostate | 645 / 21491 (3.0%) | 15498 / 214910 (7.2%) | −146.0 | −144.0 | 0.42 |
| ARID1A SRX5089379 | MCF-7 Breast | 584 / 21491 (2.7%) | 14594 / 214910 (6.8%) | −146.0 | −144.0 | 0.40 |
| EP300 SRX1012648 | MCF-7 Breast | 292 / 21491 (1.4%) | 9953 / 214910 (4.6%) | −145.8 | −143.8 | 0.29 |
| ESR1 SRX2513517 | MCF-7 Breast | 401 / 21491 (1.9%) | 11754 / 214910 (5.5%) | −145.7 | −143.6 | 0.34 |
| ESR1 SRX1012632 | MCF-7 Breast | 299 / 21491 (1.4%) | 10065 / 214910 (4.7%) | −145.6 | −143.6 | 0.30 |
| FOXA1 SRX3923511 | MCF-7 Breast | 230 / 21491 (1.1%) | 8857 / 214910 (4.1%) | −145.5 | −143.4 | 0.26 |
| AR SRX1067070 | LHSAR Prostate | 1346 / 21491 (6.3%) | 25075 / 214910 (11.7%) | −145.0 | −143.0 | 0.54 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1395 / 21491 (6.5%) | 6174 / 214910 (2.9%) | −144.8 | −142.8 | 2.26 |
| FOXA1 SRX3931033 | MCF-7 Breast | 382 / 21491 (1.8%) | 11413 / 214910 (5.3%) | −144.7 | −142.6 | 0.33 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1223 / 21491 (5.7%) | 5059 / 214910 (2.4%) | −144.6 | −142.5 | 2.42 |
| EP300 SRX2194266 | SUM 159PT Breast | 975 / 21491 (4.5%) | 20096 / 214910 (9.4%) | −144.3 | −142.3 | 0.49 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 401 / 21491 (1.9%) | 11698 / 214910 (5.4%) | −144.1 | −142.0 | 0.34 |
| MAU2 SRX15710550 | Fibroblasts Others | 939 / 21491 (4.4%) | 19583 / 214910 (9.1%) | −144.0 | −141.9 | 0.48 |
| SSRP1 SRX3436566 | HT-1080 Bone | 340 / 21491 (1.6%) | 434 / 214910 (0.2%) | −143.8 | −141.8 | 7.83 |
| JUN SRX4192884 | MCF 10A Breast | 510 / 21491 (2.4%) | 13379 / 214910 (6.2%) | −143.5 | −141.5 | 0.38 |
| ARID5B SRX10475139 | Hep G2 Liver | 638 / 21491 (3.0%) | 15293 / 214910 (7.1%) | −143.4 | −141.4 | 0.42 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 405 / 21491 (1.9%) | 11722 / 214910 (5.5%) | −143.0 | −141.0 | 0.35 |
| FOSL2 SRX190296 | SK-N-SH Neural | 775 / 21491 (3.6%) | 17246 / 214910 (8.0%) | −142.9 | −140.8 | 0.45 |
| TEAD1 SRX3401272 | MCF-7 Breast | 465 / 21491 (2.2%) | 12662 / 214910 (5.9%) | −142.9 | −140.8 | 0.37 |
| SMARCA4 SRX5212371 | Mel270 Others | 821 / 21491 (3.8%) | 17885 / 214910 (8.3%) | −142.6 | −140.6 | 0.46 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 347 / 21491 (1.6%) | 10766 / 214910 (5.0%) | −142.5 | −140.5 | 0.32 |
| PGR SRX1012655 | MCF-7 Breast | 387 / 21491 (1.8%) | 11413 / 214910 (5.3%) | −142.5 | −140.5 | 0.34 |
| ESR1 SRX5323878 | MCF-7 Breast | 592 / 21491 (2.8%) | 14571 / 214910 (6.8%) | −142.3 | −140.3 | 0.41 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1559 / 21491 (7.3%) | 27677 / 214910 (12.9%) | −142.2 | −140.2 | 0.56 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 1095 / 21491 (5.1%) | 21626 / 214910 (10.1%) | −142.2 | −140.2 | 0.51 |
| INTS3 SRX3640569 | HeLa Uterus | 1438 / 21491 (6.7%) | 6525 / 214910 (3.0%) | −141.7 | −139.7 | 2.20 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 783 / 21491 (3.6%) | 17307 / 214910 (8.1%) | −141.6 | −139.6 | 0.45 |
| PAF1 SRX15147186 | DLD-1 Digestive tract | 905 / 21491 (4.2%) | 3168 / 214910 (1.5%) | −141.5 | −139.5 | 2.86 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 179 / 21491 (0.8%) | 7795 / 214910 (3.6%) | −141.5 | −139.5 | 0.23 |
| SSRP1 SRX3436563 | HT-1080 Bone | 963 / 21491 (4.5%) | 3508 / 214910 (1.6%) | −141.4 | −139.4 | 2.75 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 1193 / 21491 (5.6%) | 22898 / 214910 (10.7%) | −141.4 | −139.4 | 0.52 |
| CXXC1 SRX1424886 | SEM Blood | 1637 / 21491 (7.6%) | 7902 / 214910 (3.7%) | −141.2 | −139.2 | 2.07 |
| RBFOX2 SRX4708082 | K-562 Blood | 2705 / 21491 (12.6%) | 15824 / 214910 (7.4%) | −141.1 | −139.2 | 1.71 |
| PBX3 SRX190343 | SK-N-SH Neural | 1176 / 21491 (5.5%) | 22655 / 214910 (10.5%) | −141.1 | −139.1 | 0.52 |
| FOXA1 SRX5323846 | MCF-7 Breast | 238 / 21491 (1.1%) | 8853 / 214910 (4.1%) | −140.9 | −138.9 | 0.27 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 992 / 21491 (4.6%) | 20171 / 214910 (9.4%) | −140.8 | −138.8 | 0.49 |
| ESR1 SRX5323877 | MCF-7 Breast | 469 / 21491 (2.2%) | 12644 / 214910 (5.9%) | −140.7 | −138.7 | 0.37 |
| FOXA1 SRX1161203 | T-47D Breast | 441 / 21491 (2.1%) | 12204 / 214910 (5.7%) | −140.6 | −138.6 | 0.36 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 579 / 21491 (2.7%) | 14300 / 214910 (6.7%) | −140.4 | −138.4 | 0.40 |
| FOXA1 SRX5203294 | MCF-7 Breast | 184 / 21491 (0.9%) | 7854 / 214910 (3.7%) | −140.4 | −138.4 | 0.23 |
| FOXA1 SRX1961157 | T-47D Breast | 646 / 21491 (3.0%) | 15286 / 214910 (7.1%) | −140.3 | −138.4 | 0.42 |
| ESR1 SRX4451214 | MCF-7 Breast | 519 / 21491 (2.4%) | 13389 / 214910 (6.2%) | −140.2 | −138.2 | 0.39 |
| FOXA1 SRX3923510 | MCF-7 Breast | 237 / 21491 (1.1%) | 8809 / 214910 (4.1%) | −140.1 | −138.1 | 0.27 |
| FOXA1 SRX1961158 | T-47D Breast | 591 / 21491 (2.7%) | 14463 / 214910 (6.7%) | −140.0 | −138.0 | 0.41 |
| ESR1 SRX10365534 | MCF-7 Breast | 192 / 21491 (0.9%) | 7987 / 214910 (3.7%) | −139.9 | −137.9 | 0.24 |
| CHD1 SRX116417 | K-562 Blood | 760 / 21491 (3.5%) | 2377 / 214910 (1.1%) | −139.7 | −137.7 | 3.20 |
| ESR1 SRX20282959 | MCF-7 Breast | 263 / 21491 (1.2%) | 9252 / 214910 (4.3%) | −139.7 | −137.7 | 0.28 |
| ESR1 SRX1995230 | MCF-7 Breast | 502 / 21491 (2.3%) | 13108 / 214910 (6.1%) | −139.5 | −137.5 | 0.38 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 626 / 21491 (2.9%) | 1680 / 214910 (0.8%) | −139.4 | −137.4 | 3.73 |
| CEBPB SRX2194250 | SUM 159PT Breast | 722 / 21491 (3.4%) | 16349 / 214910 (7.6%) | −139.4 | −137.4 | 0.44 |
| NCOA3 SRX4663589 | MCF-7 Breast | 181 / 21491 (0.8%) | 7761 / 214910 (3.6%) | −139.3 | −137.3 | 0.23 |
| 5-mC SRX882965 | LNCAP Prostate | 2597 / 21491 (12.1%) | 15054 / 214910 (7.0%) | −139.2 | −137.2 | 1.73 |
| CHD1 SRX186771 | K-562 Blood | 804 / 21491 (3.7%) | 2626 / 214910 (1.2%) | −139.2 | −137.2 | 3.06 |
| ESR1 SRX1995229 | MCF-7 Breast | 592 / 21491 (2.8%) | 14441 / 214910 (6.7%) | −139.0 | −137.0 | 0.41 |
| PRRX1 SRX15235713 | Hs 578T Breast | 734 / 21491 (3.4%) | 16502 / 214910 (7.7%) | −138.9 | −137.0 | 0.44 |
| Epitope tags SRX15939724 | RD Muscle | 530 / 21491 (2.5%) | 13503 / 214910 (6.3%) | −138.8 | −136.8 | 0.39 |
| ESR1 SRX5323872 | MCF-7 Breast | 599 / 21491 (2.8%) | 14535 / 214910 (6.8%) | −138.8 | −136.8 | 0.41 |
| ESR1 SRX2513519 | MCF-7 Breast | 336 / 21491 (1.6%) | 10452 / 214910 (4.9%) | −138.7 | −136.7 | 0.32 |
| PROX1 SRX3230397 | Hep G2 Liver | 449 / 21491 (2.1%) | 12253 / 214910 (5.7%) | −138.6 | −136.6 | 0.37 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 1100 / 21491 (5.1%) | 21524 / 214910 (10.0%) | −138.5 | −136.5 | 0.51 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 382 / 21491 (1.8%) | 11185 / 214910 (5.2%) | −138.3 | −136.3 | 0.34 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 407 / 21491 (1.9%) | 11585 / 214910 (5.4%) | −138.2 | −136.3 | 0.35 |
| AR SRX9109110 | MDA-MB-453 Breast | 1073 / 21491 (5.0%) | 21142 / 214910 (9.8%) | −138.1 | −136.1 | 0.51 |
| EP300 SRX176883 | MCF-7 Breast | 293 / 21491 (1.4%) | 9709 / 214910 (4.5%) | −138.0 | −136.1 | 0.30 |
| JUNB SRX8488074 | SUM 229PE Breast | 791 / 21491 (3.7%) | 17273 / 214910 (8.0%) | −138.0 | −136.1 | 0.46 |
| FOXA1 SRX5203307 | MCF-7 Breast | 193 / 21491 (0.9%) | 7944 / 214910 (3.7%) | −137.9 | −136.0 | 0.24 |
| ESR1 SRX1469951 | MCF-7 Breast | 323 / 21491 (1.5%) | 10211 / 214910 (4.8%) | −137.9 | −135.9 | 0.32 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 627 / 21491 (2.9%) | 14914 / 214910 (6.9%) | −137.9 | −135.9 | 0.42 |
| FOXA1 SRX3931056 | MCF-7 Breast | 365 / 21491 (1.7%) | 10889 / 214910 (5.1%) | −137.7 | −135.7 | 0.34 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 526 / 21491 (2.4%) | 13398 / 214910 (6.2%) | −137.6 | −135.7 | 0.39 |
| ESR1 SRX2881001 | MCF-7 Breast | 343 / 21491 (1.6%) | 10523 / 214910 (4.9%) | −137.5 | −135.5 | 0.33 |
| KMT2A SRX2323891 | 293 Kidney | 1074 / 21491 (5.0%) | 4252 / 214910 (2.0%) | −137.3 | −135.3 | 2.53 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 1472 / 21491 (6.8%) | 6861 / 214910 (3.2%) | −137.0 | −135.1 | 2.15 |
| ESR1 SRX2513521 | MCF-7 Breast | 303 / 21491 (1.4%) | 9842 / 214910 (4.6%) | −136.9 | −134.9 | 0.31 |
| FOXA2 SRX10475773 | Hep G2 Liver | 730 / 21491 (3.4%) | 16351 / 214910 (7.6%) | −136.7 | −134.8 | 0.45 |
| CIC SRX13262055 | Astrocytes Neural | 3370 / 21491 (15.7%) | 21294 / 214910 (9.9%) | −136.6 | −134.7 | 1.58 |
| KMT2B DRX059615 | HB1119 Blood | 990 / 21491 (4.6%) | 3752 / 214910 (1.7%) | −136.2 | −134.3 | 2.64 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1238 / 21491 (5.8%) | 5317 / 214910 (2.5%) | −136.1 | −134.2 | 2.33 |
| NFYB SRX16608147 | HeLa Uterus | 266 / 21491 (1.2%) | 243 / 214910 (0.1%) | −136.0 | −134.1 | 10.95 |
| FOXA1 SRX5323829 | T-47D Breast | 358 / 21491 (1.7%) | 10709 / 214910 (5.0%) | −135.8 | −133.8 | 0.33 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 890 / 21491 (4.1%) | 18553 / 214910 (8.6%) | −135.7 | −133.7 | 0.48 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 465 / 21491 (2.2%) | 12394 / 214910 (5.8%) | −135.5 | −133.6 | 0.38 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1531 / 21491 (7.1%) | 7299 / 214910 (3.4%) | −135.5 | −133.6 | 2.10 |
| FOXA1 SRX3931032 | MCF-7 Breast | 367 / 21491 (1.7%) | 10844 / 214910 (5.0%) | −135.4 | −133.5 | 0.34 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 318 / 21491 (1.5%) | 10037 / 214910 (4.7%) | −135.3 | −133.4 | 0.32 |
| CEBPB SRX190345 | MCF-7 Breast | 487 / 21491 (2.3%) | 12710 / 214910 (5.9%) | −135.1 | −133.1 | 0.38 |
| NANOG SRX702040 | hESC HUES64 Pluripotent stem cell | 134 / 21491 (0.6%) | 6726 / 214910 (3.1%) | −135.1 | −133.1 | 0.20 |
| FOXA1 SRX1787654 | MCF-7 Breast | 243 / 21491 (1.1%) | 8754 / 214910 (4.1%) | −135.1 | −133.1 | 0.28 |
| MLLT6 DRX059637 | 293 Kidney | 427 / 21491 (2.0%) | 808 / 214910 (0.4%) | −134.9 | −133.0 | 5.28 |
| ESR1 SRX1012633 | MCF-7 Breast | 332 / 21491 (1.5%) | 10253 / 214910 (4.8%) | −134.9 | −132.9 | 0.32 |
| ESR1 SRX5534831 | MCF-7 Breast | 477 / 21491 (2.2%) | 12546 / 214910 (5.8%) | −134.7 | −132.8 | 0.38 |
| ESR1 SRX330068 | MCF-7 Breast | 307 / 21491 (1.4%) | 9836 / 214910 (4.6%) | −134.7 | −132.8 | 0.31 |
| EP300 SRX2671813 | Fibroblasts Others | 530 / 21491 (2.5%) | 13349 / 214910 (6.2%) | −134.7 | −132.7 | 0.40 |
| GATAD2A SRX2636507 | Hep G2 Liver | 656 / 21491 (3.1%) | 15188 / 214910 (7.1%) | −134.2 | −132.3 | 0.43 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 844 / 21491 (3.9%) | 17853 / 214910 (8.3%) | −134.2 | −132.3 | 0.47 |
| ESR1 SRX176856 | MCF-7 Breast | 221 / 21491 (1.0%) | 8337 / 214910 (3.9%) | −134.2 | −132.3 | 0.27 |
| FOXA1 SRX3923513 | MCF-7 Breast | 199 / 21491 (0.9%) | 7934 / 214910 (3.7%) | −134.1 | −132.2 | 0.25 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 739 / 21491 (3.4%) | 2334 / 214910 (1.1%) | −134.0 | −132.1 | 3.17 |
| ESR1 SRX1012630 | MCF-7 Breast | 252 / 21491 (1.2%) | 8868 / 214910 (4.1%) | −133.8 | −131.9 | 0.28 |
| NR3C1 SRX2609665 | HASM2 Lung | 676 / 21491 (3.1%) | 15450 / 214910 (7.2%) | −133.6 | −131.6 | 0.44 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 714 / 21491 (3.3%) | 15987 / 214910 (7.4%) | −133.3 | −131.4 | 0.45 |
| HMG20A SRX2630163 | Hep G2 Liver | 366 / 21491 (1.7%) | 10753 / 214910 (5.0%) | −133.3 | −131.4 | 0.34 |
| FOS SRX3322636 | MCF-7 Breast | 417 / 21491 (1.9%) | 11555 / 214910 (5.4%) | −133.1 | −131.2 | 0.36 |
| JUND SRX190357 | SK-N-SH Neural | 765 / 21491 (3.6%) | 16694 / 214910 (7.8%) | −133.0 | −131.1 | 0.46 |
| FOXA1 SRX142908 | LNCAP Prostate | 334 / 21491 (1.6%) | 10218 / 214910 (4.8%) | −132.9 | −131.0 | 0.33 |
| KAT6A SRX20971022 | Fibroblasts Others | 215 / 21491 (1.0%) | 127 / 214910 (0.1%) | −132.9 | −131.0 | 16.93 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1653 / 21491 (7.7%) | 8215 / 214910 (3.8%) | −132.8 | −130.9 | 2.01 |
| JUN SRX6582172 | Fibroblasts Others | 795 / 21491 (3.7%) | 17106 / 214910 (8.0%) | −132.7 | −130.8 | 0.46 |
| GFP SRX12567758 | MRC-5 Lung | 1687 / 21491 (7.8%) | 8461 / 214910 (3.9%) | −132.7 | −130.8 | 1.99 |
| NR3C1 SRX2609662 | HASM2 Lung | 728 / 21491 (3.4%) | 16151 / 214910 (7.5%) | −132.6 | −130.7 | 0.45 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 840 / 21491 (3.9%) | 17724 / 214910 (8.2%) | −132.5 | −130.6 | 0.47 |
| RBM22 SRX4708083 | K-562 Blood | 1022 / 21491 (4.8%) | 4011 / 214910 (1.9%) | −132.4 | −130.5 | 2.55 |
| JUNB SRX10119383 | MCF 10A Breast | 441 / 21491 (2.1%) | 11903 / 214910 (5.5%) | −132.4 | −130.5 | 0.37 |
| FOXL2 SRX6957431 | KGN Gonad | 1314 / 21491 (6.1%) | 24053 / 214910 (11.2%) | −132.4 | −130.5 | 0.55 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 247 / 21491 (1.1%) | 8733 / 214910 (4.1%) | −132.4 | −130.5 | 0.28 |
| FOXA1 SRX1033292 | LNCAP Prostate | 334 / 21491 (1.6%) | 10198 / 214910 (4.7%) | −132.3 | −130.4 | 0.33 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 538 / 21491 (2.5%) | 13371 / 214910 (6.2%) | −132.2 | −130.3 | 0.40 |
| FOXA1 SRX3923509 | MCF-7 Breast | 194 / 21491 (0.9%) | 7775 / 214910 (3.6%) | −132.0 | −130.1 | 0.25 |
| GATA3 SRX100559 | T-47D Breast | 681 / 21491 (3.2%) | 15448 / 214910 (7.2%) | −131.7 | −129.8 | 0.44 |
| Epitope tags SRX5877914 | U2OS Bone | 2968 / 21491 (13.8%) | 44128 / 214910 (20.5%) | −131.6 | −129.7 | 0.67 |
| ESR1 SRX5323874 | MCF-7 Breast | 380 / 21491 (1.8%) | 10915 / 214910 (5.1%) | −131.6 | −129.7 | 0.35 |
| ESR1 SRX792933 | LY2 Breast | 513 / 21491 (2.4%) | 12974 / 214910 (6.0%) | −131.6 | −129.7 | 0.40 |
| KMT2B DRX059614 | HB1119 Blood | 971 / 21491 (4.5%) | 3715 / 214910 (1.7%) | −131.6 | −129.7 | 2.61 |
| FOXA1 SRX5323844 | MCF-7 Breast | 193 / 21491 (0.9%) | 7732 / 214910 (3.6%) | −131.2 | −129.3 | 0.25 |
| FOXA1 SRX6860635 | T-47D Breast | 482 / 21491 (2.2%) | 12482 / 214910 (5.8%) | −131.0 | −129.1 | 0.39 |
| NR3C1 SRX19024870 | MCF-7 Breast | 226 / 21491 (1.1%) | 8313 / 214910 (3.9%) | −130.8 | −128.9 | 0.27 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1731 / 21491 (8.1%) | 8829 / 214910 (4.1%) | −130.7 | −128.8 | 1.96 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 144 / 21491 (0.7%) | 6790 / 214910 (3.2%) | −130.6 | −128.8 | 0.21 |
| RAD21 SRX3482875 | hESC HUES64 Pluripotent stem cell | 932 / 21491 (4.3%) | 18874 / 214910 (8.8%) | −130.0 | −128.1 | 0.49 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 602 / 21491 (2.8%) | 14231 / 214910 (6.6%) | −130.0 | −128.1 | 0.42 |
| AR SRX1067066 | LHSAR Prostate | 1217 / 21491 (5.7%) | 22670 / 214910 (10.5%) | −129.9 | −128.0 | 0.54 |
| Epitope tags SRX1165090 | Hep G2 Liver | 701 / 21491 (3.3%) | 15660 / 214910 (7.3%) | −129.9 | −128.0 | 0.45 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 589 / 21491 (2.7%) | 14036 / 214910 (6.5%) | −129.8 | −127.9 | 0.42 |
| NR3C1 SRX19024866 | MCF-7 Breast | 239 / 21491 (1.1%) | 8502 / 214910 (4.0%) | −129.6 | −127.7 | 0.28 |
| FOXA1 SRX8537736 | MCF-7 Breast | 237 / 21491 (1.1%) | 8468 / 214910 (3.9%) | −129.6 | −127.7 | 0.28 |
| FOXA1 SRX9604647 | LNCAP Prostate | 909 / 21491 (4.2%) | 18542 / 214910 (8.6%) | −129.5 | −127.6 | 0.49 |
| FOXA1 SRX6878604 | LNCAP Prostate | 515 / 21491 (2.4%) | 12920 / 214910 (6.0%) | −129.4 | −127.5 | 0.40 |
| Epitope tags SRX1165108 | MCF-7 Breast | 523 / 21491 (2.4%) | 13037 / 214910 (6.1%) | −129.4 | −127.5 | 0.40 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 882 / 21491 (4.1%) | 18164 / 214910 (8.5%) | −129.4 | −127.5 | 0.49 |
| NR3C1 SRX2609666 | HASM2 Lung | 602 / 21491 (2.8%) | 14197 / 214910 (6.6%) | −129.1 | −127.3 | 0.42 |
| CEBPB SRX150632 | HeLa Uterus | 1314 / 21491 (6.1%) | 23893 / 214910 (11.1%) | −129.1 | −127.2 | 0.55 |
| ESR1 SRX5287697 | MCF-7 Breast | 242 / 21491 (1.1%) | 8539 / 214910 (4.0%) | −129.1 | −127.2 | 0.28 |
| FOXA1 SRX1161207 | T-47D Breast | 276 / 21491 (1.3%) | 9119 / 214910 (4.2%) | −129.0 | −127.2 | 0.30 |
| AR SRX15946405 | MDA-MB-453 Breast | 410 / 21491 (1.9%) | 11294 / 214910 (5.3%) | −129.0 | −127.1 | 0.36 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 1132 / 21491 (5.3%) | 21507 / 214910 (10.0%) | −129.0 | −127.1 | 0.53 |
| Epitope tags SRX10549777 | K-562 Blood | 2744 / 21491 (12.8%) | 16567 / 214910 (7.7%) | −128.8 | −127.0 | 1.66 |
| RAD21 SRX2630139 | Hep G2 Liver | 705 / 21491 (3.3%) | 15668 / 214910 (7.3%) | −128.7 | −126.9 | 0.45 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1150 / 21491 (5.4%) | 4891 / 214910 (2.3%) | −128.7 | −126.8 | 2.35 |
| STAT3 SRX2020842 | HCC70 Breast | 1058 / 21491 (4.9%) | 20516 / 214910 (9.5%) | −128.7 | −126.8 | 0.52 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 204 / 21491 (0.9%) | 114 / 214910 (0.1%) | −128.7 | −126.8 | 17.89 |
| AR SRX11149848 | MDA-MB-453 Breast | 411 / 21491 (1.9%) | 11297 / 214910 (5.3%) | −128.6 | −126.8 | 0.36 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 1080 / 21491 (5.0%) | 20804 / 214910 (9.7%) | −128.6 | −126.7 | 0.52 |
| SOX5 SRX2636544 | Hep G2 Liver | 623 / 21491 (2.9%) | 14482 / 214910 (6.7%) | −128.5 | −126.7 | 0.43 |
| NR3C1 SRX2609659 | HASM2 Lung | 730 / 21491 (3.4%) | 16012 / 214910 (7.5%) | −128.5 | −126.6 | 0.46 |
| FOXA1 SRX219284 | LNCAP Prostate | 820 / 21491 (3.8%) | 17263 / 214910 (8.0%) | −128.3 | −126.4 | 0.48 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 166 / 21491 (0.8%) | 7142 / 214910 (3.3%) | −128.3 | −126.4 | 0.23 |
| JUNB SRX8488089 | SUM 229PE Breast | 637 / 21491 (3.0%) | 14675 / 214910 (6.8%) | −128.3 | −126.4 | 0.43 |
| ESR1 SRX3110723 | MCF-7 Breast | 360 / 21491 (1.7%) | 10475 / 214910 (4.9%) | −128.2 | −126.3 | 0.34 |
| ESR1 SRX3110720 | MCF-7 Breast | 278 / 21491 (1.3%) | 9123 / 214910 (4.2%) | −128.2 | −126.3 | 0.30 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1317 / 21491 (6.1%) | 23876 / 214910 (11.1%) | −128.0 | −126.2 | 0.55 |
| EP300 SRX1012643 | MCF-7 Breast | 251 / 21491 (1.2%) | 8657 / 214910 (4.0%) | −128.0 | −126.1 | 0.29 |
| CBX3 SRX055348 | HCT 116 Digestive tract | 391 / 21491 (1.8%) | 710 / 214910 (0.3%) | −128.0 | −126.1 | 5.51 |
| AFF1 SRX2281250 | SEM Blood | 1052 / 21491 (4.9%) | 4281 / 214910 (2.0%) | −127.8 | −126.0 | 2.46 |
| EP300 SRX1012644 | MCF-7 Breast | 310 / 21491 (1.4%) | 9639 / 214910 (4.5%) | −127.6 | −125.8 | 0.32 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 557 / 21491 (2.6%) | 13475 / 214910 (6.3%) | −127.6 | −125.8 | 0.41 |
| FOXA1 SRX3931031 | MCF-7 Breast | 317 / 21491 (1.5%) | 9749 / 214910 (4.5%) | −127.5 | −125.6 | 0.33 |
| ESR1 SRX2513518 | MCF-7 Breast | 322 / 21491 (1.5%) | 9826 / 214910 (4.6%) | −127.2 | −125.4 | 0.33 |
| FOXA1 SRX1161205 | T-47D Breast | 359 / 21491 (1.7%) | 10417 / 214910 (4.8%) | −127.0 | −125.2 | 0.34 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 1044 / 21491 (4.9%) | 20252 / 214910 (9.4%) | −127.0 | −125.2 | 0.52 |
| ARID5B SRX10475138 | Hep G2 Liver | 1000 / 21491 (4.7%) | 19656 / 214910 (9.1%) | −126.9 | −125.1 | 0.51 |
| KMT2A SRX8151116 | VDH-15 Others | 1903 / 21491 (8.9%) | 10188 / 214910 (4.7%) | −126.7 | −124.9 | 1.87 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1871 / 21491 (8.7%) | 9953 / 214910 (4.6%) | −126.7 | −124.9 | 1.88 |
| FOXA1 SRX3923508 | MCF-7 Breast | 221 / 21491 (1.0%) | 8087 / 214910 (3.8%) | −126.5 | −124.7 | 0.27 |
| TCF21 DRX190655 | HCF Cardiovascular | 998 / 21491 (4.6%) | 19608 / 214910 (9.1%) | −126.4 | −124.6 | 0.51 |
| FOXA1 SRX9550895 | Prostate cancer Prostate | 626 / 21491 (2.9%) | 14435 / 214910 (6.7%) | −126.4 | −124.5 | 0.43 |
| RXRB SRX2636027 | Hep G2 Liver | 676 / 21491 (3.1%) | 15150 / 214910 (7.0%) | −126.3 | −124.4 | 0.45 |
| FOXA1 SRX9604645 | LNCAP Prostate | 865 / 21491 (4.0%) | 17789 / 214910 (8.3%) | −126.2 | −124.3 | 0.49 |
| KMT2A SRX8151120 | VDH-15 Others | 2335 / 21491 (10.9%) | 13468 / 214910 (6.3%) | −126.1 | −124.3 | 1.73 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 592 / 21491 (2.8%) | 13928 / 214910 (6.5%) | −126.0 | −124.2 | 0.43 |
| JUNB SRX10119384 | MCF 10A Breast | 408 / 21491 (1.9%) | 11143 / 214910 (5.2%) | −125.7 | −123.8 | 0.37 |
| ZEB1 SRX13298925 | MCF-7 Breast | 415 / 21491 (1.9%) | 11254 / 214910 (5.2%) | −125.7 | −123.8 | 0.37 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 971 / 21491 (4.5%) | 19204 / 214910 (8.9%) | −125.6 | −123.8 | 0.51 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 147 / 21491 (0.7%) | 6697 / 214910 (3.1%) | −125.5 | −123.7 | 0.22 |
| FOXA1 SRX15391842 | T-47D Breast | 370 / 21491 (1.7%) | 10540 / 214910 (4.9%) | −125.5 | −123.7 | 0.35 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 695 / 21491 (3.2%) | 15387 / 214910 (7.2%) | −125.4 | −123.6 | 0.45 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 603 / 21491 (2.8%) | 14060 / 214910 (6.5%) | −125.3 | −123.5 | 0.43 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 289 / 21491 (1.3%) | 355 / 214910 (0.2%) | −125.3 | −123.5 | 8.14 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 965 / 21491 (4.5%) | 3786 / 214910 (1.8%) | −125.1 | −123.3 | 2.55 |
| ARID1A SRX5089385 | MCF-7 Breast | 493 / 21491 (2.3%) | 12419 / 214910 (5.8%) | −125.0 | −123.2 | 0.40 |
| HDAC1 SRX17989500 | PBMC Blood | 1751 / 21491 (8.1%) | 9127 / 214910 (4.2%) | −124.9 | −123.1 | 1.92 |
| FOXA1 SRX3931073 | MCF-7 Breast | 395 / 21491 (1.8%) | 10909 / 214910 (5.1%) | −124.9 | −123.1 | 0.36 |
| ARID1A SRX5089388 | MCF-7 Breast | 348 / 21491 (1.6%) | 10164 / 214910 (4.7%) | −124.9 | −123.1 | 0.34 |
| FOXA1 SRX219285 | LNCAP Prostate | 593 / 21491 (2.8%) | 13885 / 214910 (6.5%) | −124.6 | −122.8 | 0.43 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 856 / 21491 (4.0%) | 17598 / 214910 (8.2%) | −124.6 | −122.8 | 0.49 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 192 / 21491 (0.9%) | 99 / 214910 (0.0%) | −124.6 | −122.8 | 19.39 |
| ARID1A SRX5089382 | MCF-7 Breast | 466 / 21491 (2.2%) | 11995 / 214910 (5.6%) | −124.6 | −122.8 | 0.39 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 622 / 21491 (2.9%) | 14300 / 214910 (6.7%) | −124.5 | −122.7 | 0.43 |
| DPF2 SRX3927297 | MOLM-13 Blood | 731 / 21491 (3.4%) | 15857 / 214910 (7.4%) | −124.5 | −122.7 | 0.46 |
Showing first 500 of 20429 rows.